Funding
Turn ideas into impact
Show Me
Due: January 7, 2027
National Cancer Institute’s Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
US $499,999
Type
Grant
Source
Federal
Opp Number
PAR-25-081
Due: January 7, 2027
Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
Type
Grant
Source
Federal
Opp Number
PAR-25-167
Due: January 7, 2027
Cancer Research Education Grants Program – Courses for Skills Development (R25 Clinical Trial Not Allowed)
US $300,000
Type
Grant
Source
Federal
Opp Number
PAR-23-276
Due: January 7, 2027
NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-25-032
Due: January 7, 2027
Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional)
US $250,000
Type
Grant
Source
Federal
Opp Number
PAR-25-235
Due: January 7, 2027
Cancer Research Education Grants Program – Curriculum or Methods Development (R25 Clinical Trial Not Allowed)
US $150,000
Type
Grant
Source
Federal
Opp Number
PAR-23-278
Due: January 7, 2027
Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-25-355
Due: January 7, 2027
Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-25-159
Due: January 7, 2027
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)
Type
Grant
Source
Federal
Opp Number
PAR-25-256
Submit your funding opportunity.
Do you have a grant, incentive, funding competition, or other funding source to share?